Just so everyone is aware, I don't know how high this can or will go, but my message was just in response to a trader that just got his RXMD shares blown through and is hoping like heck to be able to reload. Remember this has hit $.27 before with less than half the revenues, no SEC filing right around the corner, no potential partnership talks for uplist, no online sales, no new headquarters, 3 less pharmacy locations, and no RXMD Therapeutics subsidiary designed for sell and manufacturing of own CBD brand.
The share price potential both short term and long term is the real ?, but don't mind the frequent trader projections.
Look here in 2018 when we hit $.27, the revenue was just $20 million. CEO Mars has already projected mid in the $40+ millions for FY2020.
Market Data 
Markets 
AI
